Published in Biochem J on October 15, 1988
Protein kinase C zeta subspecies from rat brain: its structure, expression, and properties. Proc Natl Acad Sci U S A (1989) 3.21
The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature (1984) 28.58
Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem (1982) 16.71
Calculator programs for computing the composition of the solutions containing multiple metals and ligands used for experiments in skinned muscle cells. J Physiol (Paris) (1979) 15.30
Inositol trisphosphate and diacylglycerol: two interacting second messengers. Annu Rev Biochem (1987) 12.04
Phorbol diester receptor copurifies with protein kinase C. Proc Natl Acad Sci U S A (1983) 6.25
Activation of calcium and phospholipid-dependent protein kinase by diacylglycerol, its possible relation to phosphatidylinositol turnover. J Biol Chem (1980) 5.08
Diacylglycerol and phorbol ester stimulate secretion without raising cytoplasmic free calcium in human platelets. Nature (1983) 4.34
Protein kinase C as a possible receptor protein of tumor-promoting phorbol esters. J Biol Chem (1983) 3.60
Substrate specificity of protein kinase C. Use of synthetic peptides corresponding to physiological sites as probes for substrate recognition requirements. Eur J Biochem (1986) 3.37
Calcium-dependent protein kinase: widespread occurrence in various tissues and phyla of the animal kingdom and comparison of effects of phospholipid, calmodulin, and trifluoperazine. Proc Natl Acad Sci U S A (1980) 3.08
Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues. II. Proenzyme and its activation by calcium-dependent protease from rat brain. J Biol Chem (1977) 3.02
Protein kinase C activation by diacylglycerol second messengers. Cell (1986) 2.44
Characterization of a specific phorbol ester aporeceptor in mouse brain cytosol. Proc Natl Acad Sci U S A (1983) 2.23
Proteolytic activation of calcium-activated, phospholipid-dependent protein kinase by calcium-dependent neutral protease. J Biol Chem (1983) 2.20
Activation of protein kinase C by Triton X-100 mixed micelles containing diacylglycerol and phosphatidylserine. J Biol Chem (1985) 2.11
Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues. I. Purification and characterization of an active enzyme from bovine cerebellum. J Biol Chem (1977) 2.10
The phorbol ester receptor: a phospholipid-regulated protein kinase. Biochim Biophys Acta (1985) 1.99
Phospholipid-sensitive Ca2+-dependent protein kinase from heart. II. Substrate specificity and inhibition by various agents. J Biol Chem (1982) 1.83
Cooperative roles of various membrane phospholipids in the activation of calcium-activated, phospholipid-dependent protein kinase. J Biol Chem (1981) 1.66
Diacylglycerols mimic phorbol diester induction of leukemic cell differentiation. Proc Natl Acad Sci U S A (1985) 1.61
Competitive inhibition by diacylglycerol of specific phorbol ester binding. Proc Natl Acad Sci U S A (1984) 1.60
The nature of protein kinase C activation by physically defined phospholipid vesicles and diacylglycerols. J Biol Chem (1985) 1.36
Protein kinase C activation in mixed micelles. Mechanistic implications of phospholipid, diacylglycerol, and calcium interdependencies. J Biol Chem (1986) 1.23
Role of substrate in imparting calcium and phospholipid requirements to protein kinase C activation. Biochemistry (1987) 1.19
Polyamines inhibit phospholipid-sensitive and calmodulin-sensitive Ca2+-dependent protein kinases. Biochem J (1983) 1.08
Role of protein kinase C in diacylglycerol-mediated induction of ornithine decarboxylase and reduction of epidermal growth factor binding. Proc Natl Acad Sci U S A (1985) 1.08
The lipid binding, regulatory domain of protein kinase C. A 32-kDa fragment contains the calcium- and phosphatidylserine-dependent phorbol diester binding activity. J Biol Chem (1986) 1.08
Phorbol ester binding and activation of protein kinase C on triton X-100 mixed micelles containing phosphatidylserine. J Biol Chem (1986) 0.97
Ca2+ phospholipid-dependent and independent phosphorylation of synthetic peptide substrates by protein kinase C. Eur J Biochem (1987) 0.88
Stoichiometric binding of diacylglycerol to the phorbol ester receptor. J Cell Biochem (1985) 0.86
Decrease of cellular ATP by dihexanoylglycerol may limit responses to protein kinase C activation. FEBS Lett (1987) 0.78
Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol (1990) 8.85
A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol (1989) 6.30
Cromoglycate and other antiallergic drugs: a possible mechanism of action. Br Med J (1976) 2.13
Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo. Br J Pharmacol (1988) 2.02
A possible role for cyclic AMP in the regulation of histamine secretion and the action of cromoglycate. Biochem Pharmacol (1975) 1.80
Desensitization in the process of histamine secretion induced by antigen and dextran. J Physiol (1974) 1.74
A possible role for lipoxygenase products as regulators of airway smooth muscle reactivity. Br J Pharmacol (1980) 1.56
Differential histamine release by dextran and the ionophore A23187: the actions of inhibitors. Int Arch Allergy Appl Immunol (1976) 1.52
Doxantrazole, an antiallergic agent orally effective in man. Lancet (1975) 1.40
New peripheral antagonists of 5-hydroxytryptamine. Nature (1967) 1.38
Phospholipase D activation is functionally linked to superoxide generation in the human neutrophil. Biochem J (1989) 1.28
Tyrosine phosphorylation is involved in receptor coupling to phospholipase D but not phospholipase C in the human neutrophil. Biochem J (1992) 1.28
The mechanism of enhancement by fatty acid hydroperoxides of anaphylactic mediator release. Prostaglandins (1978) 1.26
Enhancement of anaphylactic mediator release from guinea-pig perfused lungs by fatty acid hydroperoxides. Prostaglandins (1978) 1.24
Demethoxyviridin and wortmannin block phospholipase C and D activation in the human neutrophil. Br J Pharmacol (1991) 1.22
Inhibition by cromoglycate of histamine release from rat peritoneal mast cells induced by mixtures of dextran, phosphatidyl serine and calcium ions. Br J Pharmacol (1974) 1.20
A device for the rapid measurement of rat foot volume. J Pharm Pharmacol (1968) 1.19
Role of oxygen radicals and arachidonic acid metabolites in the reverse passive Arthus reaction and carrageenin paw oedema in the rat. Br J Pharmacol (1993) 1.13
The temporal relationship between phospholipase activation, diradylglycerol formation and superoxide production in the human neutrophil. Biochem J (1990) 1.13
Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: effects on bronchial anaphylaxis in anaesthetized guinea-pigs. Br J Pharmacol (1988) 1.09
Receptor-coupled phospholipase D and its inhibition. Trends Pharmacol Sci (1991) 1.06
Esterification of an endogenously synthesized lipoxygenase product into granulocyte cellular lipids. Biochemistry (1981) 1.05
Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: effects on acute inflammatory responses. Br J Pharmacol (1988) 1.04
A novel and sensitive assay for phospholipase D in intact cells. FEBS Lett (1990) 1.03
Role of extracellular arachidonate in regulation of prostaglandin biosynthesis in cultured 3T3 fibroblasts. Adv Prostaglandin Thromboxane Res (1980) 0.95
Leukotriene antagonists and inhibitors of leukotriene biosynthesis as potential therapeutic agents. Prog Drug Res (1991) 0.93
The appearance of phospholipase and cyclo-oxygenase activities in the human promyelocytic leukemia cell line HL60 during dimethyl sulfoxide-induced differentiation. Biochem Biophys Res Commun (1981) 0.92
Inhibition of inducible nitric oxide synthase by acetamidine derivatives of hetero-substituted lysine and homolysine. Bioorg Med Chem Lett (2000) 0.92
Comparative pharmacology of analogues of S-nitroso-N-acetyl-DL-penicillamine on human platelets. Br J Pharmacol (1994) 0.91
Effect of cromoglycate on anaphylactic histamine release from rat peritoneal mast cells. Br J Pharmacol (1973) 0.89
The role of cell-fixed calcium in histamine release by compound 48/80. Br J Pharmacol (1979) 0.88
Modulation of bronchoconstrictor responses to histamine in pithed guinea-pigs by sympathetic nerve stimulation. Br J Pharmacol (1982) 0.87
A quantitative investigation into the dependence of Ca2+ mobilisation on changes in inositol 1,4,5-trisphosphate levels in the stimulated neutrophil. Br J Pharmacol (1991) 0.87
Modification of human airway smooth muscle reactivity by drugs that interfere with arachidonic acid metabolism. Br J Pharmacol (1982) 0.87
The generation and metabolism of leukotrienes in the ionophore-stimulated blood of normal and asthmatic subjects. Pulm Pharmacol (1990) 0.86
Indolocarbazoles: potent, selective inhibitors of human cytomegalovirus replication. Bioorg Med Chem (1999) 0.85
Chemotactic peptide stimulated endogenous arachidonic acid metabolism in HL-60 granulocytes. Biochem Biophys Res Commun (1981) 0.85
A possible modulatory role for prostacyclin (PGI2) INIgGa-induced release of slow-reacting substance of anaphylaxis in rats. Br J Pharmacol (1977) 0.85
The lipoxygenase product, 5-hydroperoxy-arachidonic acid, augments chemotactic peptide-stimulated arachidonic acid release from HL60 granulocytes. Biochem Biophys Res Commun (1982) 0.84
Inhibition of phorbol ester stimulated superoxide production by 1-oleoyl-2-acetyl-sn-glycerol (OAG); fact or artefact? FEBS Lett (1986) 0.84
A method for the comparative assessment of antioxidants as peroxyl radical scavengers. Biochem Pharmacol (1989) 0.84
Thrombin and bradykinin modulate prostaglandin synthetase independently of phospholipase. Adv Prostaglandin Thromboxane Res (1980) 0.83
The effects of a novel series of selective inhibitors of arachidonate 5-lipoxygenase on anaphylactic and inflammatory responses. Ann N Y Acad Sci (1988) 0.83
The production of 5-HETE and leukotriene B in rat neutrophils from carrageenan pleural exudates. Prostaglandins (1981) 0.82
Evidence that a second stereochemical centre in diacylglycerols defines interaction at the recognition site on protein kinase C. FEBS Lett (1988) 0.81
A phorbol ester and a daphnane ester stimulate a calcium-independent kinase activity from human mononuclear cells. FEBS Lett (1989) 0.81
Phospholipase D: regulation and functional significance. Adv Pharmacol (1993) 0.80
Stimulation and inhibition of secretion by phorbol myristate acetate in different cell types. Biochem Biophys Res Commun (1985) 0.80
Inhibition by cromoglycate of histamine release induced by dextran plus phosphatidyl serine. Br J Pharmacol (1973) 0.80
Role of c-lyn in the functional effects of GM-CSF on human neutrophils. Biochem Soc Trans (1995) 0.80
Selectivity of protein kinase inhibitors in human intact platelets. Cell Signal (1990) 0.78
Decrease of cellular ATP by dihexanoylglycerol may limit responses to protein kinase C activation. FEBS Lett (1987) 0.78
The relationship between energy metabolism and the action of inhibitors of histamine release. Br J Pharmacol (1977) 0.78
Separation of IgE from IgG subclasses using staphylococcal protein A. Int Arch Allergy Appl Immunol (1978) 0.77
The extraneuronal O-methylation of 3H-(+)isoprenaline by guinea-pig tracheal rings in vitro. Naunyn Schmiedebergs Arch Pharmacol (1981) 0.77
Inhibition of 5-lipoxygenase: development of hydroxamic acids and hydroxyureas as potential therapeutic agents. Adv Prostaglandin Thromboxane Leukot Res (1991) 0.77
Hydroxamic acids and hydroxyureas as novel, selective 5-lipoxygenase inhibitors for possible use in asthma. Agents Actions Suppl (1991) 0.77
Indolocarbazoles: potent and selective inhibitors of platelet-derived growth factor receptor autophosphorylation. Biochem Pharmacol (1998) 0.76
Proceedings: An improved apparatus for automatic sampling and the control of isolated preparations. Br J Pharmacol (1974) 0.75
Mechanism of A23187 induced histamine release [proceedings]. Br J Pharmacol (1978) 0.75
Interaction between barium, strontium and calcium in histamine release by compound 48/80. Eur J Pharmacol (1978) 0.75
Synthesis of N-alkyl substituted indolocarbazoles as potent inhibitors of human cytomegalovirus replication. Bioorg Med Chem Lett (2001) 0.75
The incorporation of [1(-14)C] acetate into unesterified fatty acids in rat cerebral cortex in vivo. J Neurochem (1976) 0.75
Incorporation of [1-14C]acetate into the long-chain-fatty acyl-coenzyme A esters of rat brain in vivo [proceedings]. Biochem Soc Trans (1978) 0.75
Selective 5-lipoxygenase inhibitor BW A4C does not influence progression of tissue injury in a canine model of regional myocardial ischaemia and reperfusion. J Cardiovasc Pharmacol (1991) 0.75
Development of a novel series of trialkoxyaryl derivatives as specific and competitive antagonists of platelet activating factor. J Med Chem (1995) 0.75
The long-chain fatty acyl-coenzyme A hydrolase activity of rat cerebral cortex. Biochem Soc Trans (1976) 0.75
Construction and expression of a functional chimeric receptor from PDGFr-beta and c-erbB-2. Biochem Soc Trans (1995) 0.75
The effects of a 5-lipoxygenase inhibitor, BW A4C, on the acute response to inhaled PAF in man. Ann N Y Acad Sci (1991) 0.75
Effects of the indolocarbazole 3744W on the tyrosine kinase activity of the cytoplasmic domain of the platelet-derived growth factor beta-receptor. Cell Signal (1999) 0.75
Effects of tryptophan 2,3-dioxygenase inhibitors in the rat. Adv Exp Med Biol (1991) 0.75
Alkaloids of Calabash curare and Strychnos species. IV. Caracurine-II. J Chem Soc Perkin 1 (1967) 0.75
Phospholipase D activation in PDGF-stimulated vascular smooth muscle cells. Biochem Soc Trans (1993) 0.75
A commentary on the inhibition by retinoids of leukotriene B4 production in leukocytes. FEBS Lett (1987) 0.75